PHE have issued their latest briefing. This shows why B.1.617.2 (also called VOC-21APR-02) has been classified as a Variant of Concern.
This is mainly justified on transmissibility.
"Transmissibility appears greater than wild-type SARS-COV-2 ...
" ... B.1.617.2 is assessed as at least as transmissible as B.1.1.7 with moderate confidence. This is biologically plausible based on the mutation profile. This assessment is supported by evidence that it can compete with B.1.1.7 in the population and modelled growth estimates...
" ... suggesting transmissibility at least equal to B.1.1.7."
There are also *LOW CONFIDENCE* concerns in relation to susceptibility and immunity from natural infection
and *LOW CONFIDENCE* concerns in relation to vaccines
However, *IMPORTANTLY*
"There are insufficient data as yet to assess reinfection or vaccine effectiveness through national surveillance."
*NO DEATHS* have yet been associated with B.1.617.2 (VOC-21APR-02)
You can see the increase in prevalence of B.1.617.2 (VOC-21APR-02) in this chart where purple/lilac is B.1.617.2
This is the regional breakdown of the proportion of cases that are B.1.617.2 in each region.
However, cases in the South West are very low, and these are predominanty related to travel.
London appears to be an issue.
Many of these cases are still 'under investigation' (in grey), therefore not (yet) associated with travel or contacts of travellers.
This is the breakdown of where B.1.617.2 has been detected - London; north-west; midland towns; Bristol area.
"Ratio values >1 indicate an increased risk and values <1 indicate lower risk."
Circled areas show the areas where this is statistically significant.
Once again, many thanks to the hard work of @PHE_uk and the groups that support the analysis.
*relative prevalence
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Most of these cases were related to travellers. We have since required quarantine for people that have been in India. So this should (in theory) reduce significantly the import of B.1.617.2
"In addition to the direct effects of preventing cases and reducing severity, we have shown that both the ChAdOx1 nCoV-19 and BNT162b2 vaccines are associated with reduced likelihood of household transmission by 40-50% from individuals diagnosed with COVID-19 after vaccination...
Travel is starting to split into countries with low Covid cases and countries without low Covid cases.
A short thread.
Singapore and Hong Kong have announced a travel bubble
"All passengers departing from Hong Kong are required to be vaccinated, and passengers from both cities are expected to take a test within three days of departure and again on arrival."
Public Health England have updated their analysis of Variants of Concern and Variants under Investigation. It is great that this expert analysis has been published.
Some commentary.
Firstly, the India variant (B.1.617). This has been split. Only B.1.617.1 with E484Q is a Variant under Investigation.
Variants of Concern remain
B.1.1.7 (UK/Kent)
B.1.351 (South Africa)
P.1 (Manaus)
B.1.1.7 with E484K
Several other variants are being monitored.
This is PHE's chart of variant prevalence. As you can see, B.1.1.7 (Kent variant) dominates (purple)
The latest @PHE_UK variant data has been published for the UK. First, the heatmap of new cases.
Significantly:
P1 (Manaus) has increased from 40 to 60 total cases
B.1.617 (India) has increased from 77 to 132 total cases.
B.1.351 (SA) has increased from 600 to 670 total cases
Here is my Covid variants cumulative chart (excluding UK variant).